Consensus Recommendations on Initiating Prescription Therapies for Opioid-Induced Constipation
Charles E. Argoff(Albany Medical Center Hospital), Lynn R. Webster(Adherent Technologies (United States)), Michael J. Brennan(Center for Biologics Evaluation and Research), Andrew Davies(GW Pharmaceuticals (United Kingdom)), Jeffrey Fudin(University of Connecticut), Anthony Lembo(Cleveland Clinic), Katherine E. Galluzzi(Philadelphia College of Osteopathic Medicine), Michael Camilleri(CSIRO Manufacturing), Jeffrey Gudin(Rutgers, The State University of New Jersey), Steven P. Stanos(Pain and Headache Center)
Cited by 117
Related Papers
Bowel Disorders
|Gastroenterology|2016|2.8k
Functional Gastroduodenal Disorders
|Gastroenterology|2006|2.4k
Components of placebo effect: randomised controlled trial in patients with irritable bowel syndrome
|BMJ|2008|1.2k